← All Sponsors
SPONSOR

Pr Bruno LEVY

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Cardiogenic Shock
NCT04020263 Phase 3
Recruiting

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Cardiogenic Shock
France View Trial →